Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
2.070
+0.050 (2.48%)
At close: Sep 26, 2025, 4:00 PM EDT
2.070
0.00 (0.01%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $94.66 million as of September 26, 2025. Its market cap has decreased by -3.30% in one year.
Market Cap
94.66M
Enterprise Value
54.21M
1-Year Change
-3.30%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $94.66M, a decrease of -78.51%. That is a compound annual growth rate of -29.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 94.66M | 43.52% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |